TotalMarketCap

Pulmatrix

PULMNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$5.314 M

$1.46 -4.28%

Close of 6 Nov 2026

As of 6 Nov 2026, Pulmatrix (PULM) has a market capitalization of $5.31M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$7.81M

#3180 by revenue

Earnings

-$5.16M

Loss-making

Shares outstanding

3,652,285

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #446Acurx PharmaceuticalsACXP$5.39M
  2. #447Jaguar HealthJAGX$5.35M
  3. #448PulmatrixPULM$5.31M
  4. #449Processa PharmaceuticalsPCSA$5.26M
  5. #450ScientureSCNX$5.18M

What if Pulmatrix were worth as much as…

Open the what-if tool →

Gold $28.2T

$7,731,289

Per share 5,313,601× higher

Bitcoin $1.53T

$418,326.60

Per share 287,510× higher

Apple $5.02T

$1,373,327

Per share 943,867× higher

Or at a round number

$10.0M$20.0M$50.0M$100.0M

Where these numbers come from

Share counts and financials for Pulmatrix are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.